|
|||||
|
|
| 从马兜铃酸问题看中药国际化 | |
| 引用本文： | 胡世林 许有玲. 从马兜铃酸问题看中药国际化[J]. 世界科学技术, 2001, 3(2): 5-8 |
| 作者姓名： | 胡世林 许有玲 |
| 作者单位： | [1]香港浸会大学中医药学院，香港 [2]国家自然科学基金委员 |
| 摘 要： | 本文综述了目前国际界较敏感的停止进口含马兜铃酸(aristolochic acid,简称AA）的中药材（广防已、关木通等）的原因和背景，提出运用道地药材理论，研究安全使用的方略，建议用马兜铃酸肾病AAN（Aristolochic Acid Nephropathy)来取代中药肾病CHN（Chinese Herb Hephropathy)，因为不是所有的中药都会引起肾病，不能跟随西方人使用扩大的，不够严密准确的术语。 |
| 关 键 词： | 马兜铃 马兜铃酸 广防已 关木通 中药国际化 安全性 中药材 马兜铃酸肾病 |
Viewing Internationalization of Traditional Chinese Medicine from Aristolochic Acids |
|
| Hu Shilin. Viewing Internationalization of Traditional Chinese Medicine from Aristolochic Acids[J]. World Science and Technology(Modernization of Traditional Chinese Medicine), 2001, 3(2): 5-8 | |
| Authors: | Hu Shilin |
| Abstract: | The article reviews the reasons and background of banning import of Chinese medicinal herbs containing aristolochic acid (AA), such as Guangfangji and Guanmutong, in some western countries,and puts forward some ways of using them safely on the basis of theories of genuine Chinese medicinal materials, and suggests that Chinese herb nephropathy (CHN) should be replaced by aristolochic acid nephropathy (AAN) because only a few Chinese medicinal herbs contain AA . Therefore, it is unfit to follow some westerners to use such terms as improperly expanded and imprecisely named in their usage. |
| Keywords: | aristolochic aristolochic acid Guangfangji Guanmutong |
| 本文献已被 CNKI 维普 等数据库收录！ | |